Go to New York Times to read this article:
"Addiction Diagnoses May Rise Under Guideline Changes"

What most disturbed me was the Pharmaceutical industry's input into the revision of the DMS which affects us all, which is the bible of Psychiatric diagnosis' , it is very very disturbing to have "business" interest interfere with purely medial/psychiatric standards. WOW